Fenoterol

CHEMBL32800 Phase 4 Disetujui Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
303.4 g/mol
LogP
2.0
Phase
4

This medication is a bronchodilator that relaxes the muscles around the airways, making breathing easier for people with asthma and chronic obstructive pulmonary disease. It works by stimulating beta-2 receptors in the lungs to open constricted air passages.

Berat Molekul

303,3500 g/mol

LogP

2,00

TPSA

93,00 Ų

Lipinski RO5

Lulus

Area Terapeutik

Mekanisme Kerja

Activates beta-2 adrenergic receptors on bronchial smooth muscle, stimulating adenylyl cyclase and increasing intracellular cAMP. This relaxes airway smooth muscle and produces bronchodilation.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mekanisme

Activates beta-2 adrenergic receptors on bronchial smooth muscle, stimulating adenylyl cyclase and increasing intracellular cAMP. This relaxes airway smooth muscle and produces bronchodilation.

Struktur 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CC(Cc1ccc(O)cc1)NCC(O)c1cc(O)cc(O)c1

InChI

InChI=1S/C17H21NO4/c1-11(6-12-2-4-14(19)5-3-12)18-10-17(22)13-7-15(20)9-16(21)8-13/h2-5,7-9,11,17-22H,6,10H2,1H3

Molecular Formula

C17H21NO4

HBD / HBA

5 / 5

Ikatan yang Dapat Dirotasi

6

Atom Berat

22

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Pertanyaan yang Sering Diajukan

This medication is a bronchodilator that relaxes the muscles around the airways, making breathing easier for people with asthma and chronic obstructive pulmonary disease. It works by stimulating beta-2 receptors in the lungs to open constricted air passages.

Activates beta-2 adrenergic receptors on bronchial smooth muscle, stimulating adenylyl cyclase and increasing intracellular cAMP. This relaxes airway smooth muscle and produces bronchodilation.

Yes, Fenoterol is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL32800. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 3343. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Penyangkalan Medis

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.